• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明尼苏达州奥姆斯特德县肾小球疾病发病率的变化:一项为期30年的肾活检研究。

Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study.

作者信息

Swaminathan Sundararaman, Leung Nelson, Lager Donna J, Melton L Joseph, Bergstralh Eric J, Rohlinger Audrey, Fervenza Fernando C

机构信息

Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

出版信息

Clin J Am Soc Nephrol. 2006 May;1(3):483-7. doi: 10.2215/CJN.00710805. Epub 2006 Apr 19.

DOI:10.2215/CJN.00710805
PMID:17699249
Abstract

Membranous nephropathy (MN) is considered the most common cause of nephrotic syndrome in white adults, but recent studies have shown an increasing incidence of focal segmental glomerulosclerosis (FSGS). These studies are difficult to interpret because the majority of cases came from urban tertiary referral centers. For validating these findings in the general population, trends in the incidence of various forms of glomerular disease (glomerulonephritis [GN]) among the residents of Olmsted County, MN were studied. Biopsy data of local patients who had a diagnosis of a nondiabetic glomerular disease from 1974 through 2003 were reviewed. Biopsies were categorized as (1) FSGS, (2) MN, (3) minimal change, (4) lupus nephritis, (5) membranoproliferative GN (MPGN), (6) IgA nephropathy (IgAN), (7) crescentic/necrotizing GN, and (8) other. Time trends in the annual age- and gender-adjusted (2000 US population) incidence rate per 100,000 Olmsted County population were estimated. A total of 195 biopsies were analyzed. Overall, IgAN was present in 22%, FSGS was present in 17%, and MN was present in 10%. Between 1974 to 1983 and 1994 to 2003, the incidence of any type of GN among Olmsted County residents increased more than two-fold (P < 0.001), FSGS by 13-fold (P < 0.001), and IgAN by three-fold (P = 0.002). Increases in MN were nonsignificant (2.5-fold; P = 0.13). Currently (1994 to 2003), the most frequent type of GN is IgAN (25%), followed by FSGS (20%) and MN (11%), with annual incidence rates of 2.1, 1.8, and 1.0 per 100,000/yr, respectively. This study confirms that the incidence of GN is growing overall, particularly for FSGS, which is the leading cause of nephrotic syndrome in white adults.

摘要

膜性肾病(MN)被认为是白人成年人肾病综合征最常见的病因,但最近的研究表明局灶节段性肾小球硬化症(FSGS)的发病率在上升。由于大多数病例来自城市三级转诊中心,这些研究结果难以解读。为了在普通人群中验证这些发现,我们研究了明尼苏达州奥尔姆斯特德县居民中各种形式肾小球疾病(肾小球肾炎[GN])的发病率趋势。回顾了1974年至2003年当地诊断为非糖尿病性肾小球疾病患者的活检数据。活检分为以下几类:(1)FSGS,(2)MN,(3)微小病变,(4)狼疮性肾炎,(5)膜增生性肾小球肾炎(MPGN),(6)IgA肾病(IgAN),(7)新月体/坏死性肾小球肾炎,以及(8)其他。估计了奥尔姆斯特德县每10万人口按年龄和性别调整(2000年美国人口)后的年发病率的时间趋势。总共分析了195份活检样本。总体而言,IgAN占22%,FSGS占17%,MN占10%。在1974年至1983年与1994年至2003年期间,奥尔姆斯特德县居民中任何类型GN的发病率增加了两倍多(P < 0.001),FSGS增加了13倍(P < 0.001),IgAN增加了三倍(P = 0.002)。MN的增加不显著(2.5倍;P = 0.13)。目前(1994年至2003年),最常见的GN类型是IgAN(25%),其次是FSGS(20%)和MN(11%),年发病率分别为每10万/年2.1、1.8和1.0。这项研究证实GN的发病率总体上在上升,尤其是FSGS,它是白人成年人肾病综合征的主要病因。

相似文献

1
Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study.明尼苏达州奥姆斯特德县肾小球疾病发病率的变化:一项为期30年的肾活检研究。
Clin J Am Soc Nephrol. 2006 May;1(3):483-7. doi: 10.2215/CJN.00710805. Epub 2006 Apr 19.
2
Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience.韩国成年人肾小球疾病患病率的变化:20年经验回顾
Nephrol Dial Transplant. 2009 Aug;24(8):2406-10. doi: 10.1093/ndt/gfp091. Epub 2009 Mar 4.
3
The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000.捷克肾脏活检登记处。1994 - 2000年肾脏疾病的发病情况。
Nephrol Dial Transplant. 2004 Dec;19(12):3040-9. doi: 10.1093/ndt/gfh521. Epub 2004 Oct 26.
4
The changing pattern of adult primary glomerular disease.成人原发性肾小球疾病的变化模式。
Nephrol Dial Transplant. 2009 Oct;24(10):3050-4. doi: 10.1093/ndt/gfp254. Epub 2009 Jun 1.
5
An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9,617 native kidney biopsies.巴西肾活检诊断频率概述:基于 9617 例原发性肾脏活检的临床和病理模式。
Nephrol Dial Transplant. 2010 Feb;25(2):490-6. doi: 10.1093/ndt/gfp355. Epub 2009 Jul 24.
6
Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases.罗马尼亚肾脏疾病流行病学:对两个地区肾脏活检数据库的十年回顾。
Nephrol Dial Transplant. 2006 Feb;21(2):419-24. doi: 10.1093/ndt/gfi207. Epub 2005 Oct 25.
7
Primary glomerulonephritis: an update on renal survival and determinants of progression.原发性肾小球肾炎:肾脏存活率及疾病进展决定因素的最新进展
QJM. 2008 Mar;101(3):215-24. doi: 10.1093/qjmed/hcm142. Epub 2008 Feb 2.
8
Prevalence and clinical findings of biopsy-proven glomerulonephritidis in Iran.伊朗经活检证实的肾小球肾炎的患病率及临床发现
Saudi J Kidney Dis Transpl. 2007 Nov;18(4):556-64.
9
An analysis of 4,514 cases of renal biopsy in Korea.对韩国4514例肾活检病例的分析。
Yonsei Med J. 2001 Apr;42(2):247-54. doi: 10.3349/ymj.2001.42.2.247.
10
[The incidence of renal diseases as diagnosed by biopsy in Hungary].[匈牙利经活检诊断的肾脏疾病发病率]
Orv Hetil. 2004 Jun 27;145(26):1373-9.

引用本文的文献

1
Cost per Response of Acthar® Gel vs Standard of Care for the Treatment of Proteinuria in Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy Among Adults from the US Healthcare Perspective.从美国医疗保健角度看,Acthar®凝胶与标准治疗方案治疗成人特发性膜性肾病所致肾病综合征蛋白尿的每反应成本。
J Health Econ Outcomes Res. 2025 Aug 6;12(2):50-61. doi: 10.36469/001c.142078. eCollection 2025.
2
Clinical Outcomes in the Nephrotic Syndrome Study Network: Disease Burden and Treatment Patterns over Time.肾病综合征研究网络的临床结局:疾病负担及随时间变化的治疗模式
Glomerular Dis. 2025 Jun 5;5(1):288-303. doi: 10.1159/000546655. eCollection 2025 Jan-Dec.
3
Biopsy-Proven Glomerulopathies in Romania: A 10-Year Nationwide Study.
罗马尼亚经活检证实的肾小球病:一项为期10年的全国性研究。
Life (Basel). 2025 Jun 11;15(6):938. doi: 10.3390/life15060938.
4
Global and national public awareness and interest in glomerular diseases from 2004 to 2024.2004年至2024年全球及各国公众对肾小球疾病的认知与关注。
Front Nephrol. 2025 Jan 23;5:1519481. doi: 10.3389/fneph.2025.1519481. eCollection 2025.
5
Efficacy and safety of nine immunosuppressive agents for primary focal segmental glomerulosclerosis in adults: a pairwise and network meta-analysis.九种免疫抑制剂治疗成人原发性局灶节段性肾小球硬化症的疗效与安全性:一项成对和网状荟萃分析
Ren Fail. 2024 Dec;46(2):2438861. doi: 10.1080/0886022X.2024.2438861. Epub 2024 Dec 11.
6
The incidence and prevalence of immunoglobulin A nephropathy in the United States.美国免疫球蛋白A肾病的发病率和患病率。
Clin Nephrol. 2025 Jan;103(1):19-25. doi: 10.5414/CN111489.
7
Is the Prevalence of Biopsy-Proven Glomerulopathies in Adults Changing Over Time?经活检证实的成人肾小球病患病率是否随时间变化?
Maedica (Bucur). 2024 Sep;19(3):519-525. doi: 10.26574/maedica.2024.19.3.519.
8
Incidence of Adult Primary Immunoglobulin A Nephropathy among a Racially/Ethnically Diverse Population in the United States.美国不同种族/族裔人群中成人原发性免疫球蛋白A肾病的发病率。
Am J Nephrol. 2025;56(2):172-177. doi: 10.1159/000541869. Epub 2024 Nov 4.
9
Incidence and Proportion of Primary Focal Segmental Glomerulosclerosis (FSGS) among a Racially and Ethnically Diverse Adult Patient Population between 2010 and 2021.2010年至2021年期间不同种族和民族成年患者群体中原发性局灶节段性肾小球硬化(FSGS)的发病率和比例
Clin J Am Soc Nephrol. 2024 Dec 12;20(2):229-38. doi: 10.2215/CJN.0000000590.
10
Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry.原发性肾小球疾病导致的终末期肾病在欧洲进行肾脏替代治疗的发生率和结局:来自 ERA 登记处的研究结果。
Nephrol Dial Transplant. 2024 Aug 30;39(9):1449-1460. doi: 10.1093/ndt/gfae034.